Table 2. Univariate Cox regression analysis of XRCC1 expression and clinicopathological variables predicting the survival of renal cancer patients.
| Variables | Overall survival | Disease specific survival | ||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| XRCC1 expression (Low vs. High) | 0.71(0.50–0.99) | 0.049 | 0.67 (0.46–0.97) | 0.038 |
| Age (≤56 vs. >56) | 1.08 (0.81–1.43) | 0.608 | 1.04 (0.77–1.41) | 0.798 |
| Tumor diameter (≤7 cm vs. >7 cm) | 1.62 (1.14–2.30) | 0.007 | 1.44 (0.96–2.17) | 0.008 |
| pT status (pT1/pT2 vs. pT3/pT4) | 1.52 (1.07–2.15) | 0.019 | 1.34 (0.90–2.00) | 0.014 |
| TNM stage (I–II vs. III–IV) | 1.67 (1.17–2.38) | 0.005 | 1.40 (0.94–2.10) | 0.009 |
Abbreviations: HR: hazard ratio; CI: confidence interval.